MEDP
Medpace Holdings, Inc. · Healthcare · Medical - Diagnostics & Research
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2026
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 45.76K | $27.51M | n/a | −1 |
| Q2 2026 | 129 | -10 | 16.75M | $8.87B | +3 | −14 |
| Q1 2026 | 143 | -2 | 15.75M | $7.54B | +5 | −8 |
| Q4 2025 | 145 | 0 | 17.01M | $9.56B | +1 | n/a |
| Q3 2025 | 22 | 0 | 10.56M | $5.42B | +1 | −2 |
| Q2 2025 | 20 | +1 | 9.67M | $3.03B | +1 | n/a |
| Q1 2025 | 16 | -1 | 3.77M | $1.14B | n/a | −1 |
| Q4 2024 | 17 | +1 | 4.06M | $1.35B | +1 | n/a |
| Q3 2024 | 15 | -1 | 3.56M | $1.19B | n/a | −1 |
| Q2 2024 | 16 | n/a | 3.05M | $1.26B | n/a | n/a |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Assenagon Asset Management S.A. | 24.77K | -52.0% | $15.46M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 2 | Wealth Enhancement Advisory… | 20.82K | +30.8% | $11.95M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | TD Waterhouse Canada Inc. | 170 | +39.3% | $101,590 | 0.0% | ▲ Add | 4 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Assetmark, Inc | $60,903 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 724 持有人, 23.89M 股份, $10.71B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Officer, Director, 10% owner · 21.97K 股 · $13.74M
Officer, Director, 10% owner · 26.70K 股 · $16.58M
Officer, Director, 10% owner · 2.41K 股 · $1.49M
Officer, Director, 10% owner · 154 股 · $95,572
Officer, Director, 10% owner · 27.83K 股 · $17.29M
Officer, Director, 10% owner · 16.08K 股 · $10.11M
Officer, Director, 10% owner · 49.02K 股 · $30.79M
Officer, Director, 10% owner · 21.88K 股 · $13.64M
Officer, Director, 10% owner · 10.88K 股 · $6.75M
Officer, Director, 10% owner · 8.77K 股 · $5.45M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
19.1% 占股份类别 · 查看 SEC 原始申报文件 ↗